Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · page 10 of 38
The slide outlines a multi-part clinical trial design with specific dosing cohorts and eligibility requirements.
Pitch deck · appendix_methodology · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 diagram 1/1 list 2/2 title 1/1
Components 5
primary process bullet bullet headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1